| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.002 | 0.733 | ALK inhibitor | 0.6 0.003 DBMET01404 0.721 0.002 DBMET02145 0.531 0.003 DBMET02146 0.545 0.003 DBMET02147 | ||
| 0.408 | 0.02 | 0.416 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.38 0.026 DBMET01404 0.416 0.018 DBMET02145 0.286 0.075 DBMET02146 0.315 0.054 DBMET02147 | DBMET02145 | |
| 0.365 | 0.081 | 0.405 | MAP kinase kinase 6 inhibitor | 0.278 0.158 DBMET01404 0.405 0.055 DBMET02145 | DBMET02145 | |
| 0.334 | 0.159 | 0.334 | Caspase 9 stimulant | 0.283 0.213 DBMET01404 0.258 0.244 DBMET02145 | ||
| 0.184 | 0.018 | 0.184 | Antineoplastic alkaloid | 0.112 0.041 DBMET01404 0.112 0.041 DBMET02145 0.086 0.059 DBMET02146 0.095 0.05 DBMET02147 | ||
| 0.215 | 0.06 | 0.291 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.164 0.085 DBMET01404 0.291 0.034 DBMET02145 | DBMET02145 | |
| 0.229 | 0.078 | 0.229 | Potassium channel (Voltage-sensitive) blocker | 0.148 0.139 DBMET01404 0.22 0.083 DBMET02145 | ||
| 0.189 | 0.04 | 0.189 | Toll-Like receptor 9 antagonist | 0.107 0.102 DBMET01404 | ||
| 0.233 | 0.09 | 0.233 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.218 0.12 DBMET02145 | ||
| 0.22 | 0.081 | 0.22 | Potassium channel blocker | 0.146 0.139 DBMET02145 | ||
| 0.172 | 0.042 | 0.179 | Toll-Like receptor antagonist | 0.179 0.039 DBMET01404 0.162 0.048 DBMET02145 | DBMET01404 | |
| 0.163 | 0.036 | 0.171 | Topoisomerase I inhibitor | 0.152 0.04 DBMET01404 0.171 0.034 DBMET02145 0.137 0.047 DBMET02146 0.119 0.056 DBMET02147 | DBMET02145 | |
| 0.161 | 0.046 | 0.161 | MAP3K9 inhibitor | 0.145 0.068 DBMET01404 0.146 0.067 DBMET02145 0.135 0.085 DBMET02147 | ||
| 0.138 | 0.026 | 0.138 | Acetylcholine M3 receptor agonist | |||
| 0.175 | 0.075 | 0.209 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.183 0.072 DBMET01404 0.209 0.06 DBMET02145 | DBMET02145 | |
| 0.123 | 0.031 | 0.123 | Potassium channel activator | 0.095 0.054 DBMET01404 0.113 0.037 DBMET02145 | ||
| 0.119 | 0.03 | 0.119 | mTOR complex 1 inhibitor | |||
| 0.184 | 0.1 | 0.184 | HERG channel blocker | 0.177 0.105 DBMET02145 | ||
| 0.275 | 0.191 | 0.284 | Apoptosis agonist | 0.274 0.192 DBMET01404 0.281 0.186 DBMET02145 0.284 0.184 DBMET02146 | DBMET02146 | |
| 0.118 | 0.034 | 0.118 | Androgen antagonist | 0.086 0.059 DBMET01404 0.087 0.058 DBMET02145 0.087 0.058 DBMET02147 | ||
| 0.178 | 0.096 | 0.195 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.19 0.084 DBMET01404 0.195 0.08 DBMET02145 | DBMET02145 | |
| 0.11 | 0.032 | 0.159 | MAP-kinase-activated kinase inhibitor | 0.103 0.036 DBMET01404 0.159 0.012 DBMET02145 0.077 0.066 DBMET02146 0.075 0.07 DBMET02147 | DBMET02145 | |
| 0.116 | 0.045 | 0.116 | Insulin receptor antagonist | 0.096 0.068 DBMET02145 | ||
| 0.096 | 0.031 | 0.148 | MAP-kinase-activated kinase 2 inhibitor | 0.093 0.032 DBMET01404 0.148 0.011 DBMET02145 0.07 0.058 DBMET02146 0.068 0.062 DBMET02147 | DBMET02145 | |
| 0.12 | 0.057 | 0.142 | DNA intercalator | 0.132 0.051 DBMET01404 0.142 0.046 DBMET02145 0.1 0.073 DBMET02146 | DBMET02145 | |
| 0.088 | 0.03 | 0.095 | Toll-Like receptor 7 antagonist | 0.073 0.044 DBMET01404 0.095 0.025 DBMET02145 | DBMET02145 | |
| 0.143 | 0.087 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.065 | 0.016 | 0.065 | Aldosterone antagonist | 0.061 0.019 DBMET01404 0.064 0.017 DBMET02145 | ||
| 0.069 | 0.031 | 0.08 | Androgen agonist | 0.062 0.038 DBMET01404 0.059 0.042 DBMET02145 0.08 0.024 DBMET02147 | DBMET02147 | |
| 0.05 | 0.014 | 0.056 | Retinoic acid alpha receptor agonist | 0.056 0.011 DBMET01404 0.055 0.011 DBMET02145 0.055 0.011 DBMET02146 0.055 0.011 DBMET02147 | DBMET01404 | |
| 0.063 | 0.029 | 0.079 | Toll-Like receptor 8 antagonist | 0.048 0.044 DBMET01404 0.079 0.018 DBMET02145 | DBMET02145 | |
| 0.092 | 0.06 | 0.13 | Protein kinase C delta inhibitor | 0.086 0.068 DBMET01404 0.13 0.031 DBMET02145 | DBMET02145 | |
| 0.082 | 0.055 | 0.082 | Phosphodiesterase XI inhibitor | |||
| 0.082 | 0.055 | 0.082 | Phosphodiesterase 11A inhibitor | |||
| 0.124 | 0.098 | 0.133 | CC chemokine 6 receptor antagonist | 0.127 0.081 DBMET01404 0.133 0.059 DBMET02145 0.121 0.111 DBMET02146 0.121 0.114 DBMET02147 | DBMET02145 | |
| 0.16 | 0.142 | 0.222 | Vasodilator | 0.171 0.13 DBMET01404 0.221 0.088 DBMET02146 0.222 0.088 DBMET02147 | DBMET02147 | |
| 0.114 | 0.098 | 0.114 | Interleukin 1 antagonist | |||
| 0.101 | 0.085 | 0.143 | Topoisomerase II inhibitor | 0.136 0.056 DBMET01404 0.143 0.053 DBMET02145 0.107 0.079 DBMET02146 | DBMET02145 | |
| 0.068 | 0.054 | 0.087 | Telomerase inhibitor | 0.078 0.046 DBMET01404 0.087 0.04 DBMET02145 | DBMET02145 | |
| 0.062 | 0.049 | 0.085 | 5 Hydroxytryptamine 1B antagonist | 0.085 0.032 DBMET02145 | DBMET02145 | |
| 0.123 | 0.111 | 0.123 | Sigma receptor agonist | |||
| 0.137 | 0.127 | 0.161 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.161 0.103 DBMET02145 | DBMET02145 | |
| 0.039 | 0.03 | 0.039 | DNA-dependent protein kinase inhibitor | |||
| 0.078 | 0.073 | 0.078 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.025 | 0.024 | 0.029 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET01404 0.027 0.019 DBMET02145 0.029 0.014 DBMET02146 0.029 0.015 DBMET02147 | DBMET02147 | |
| 0.088 | 0.089 | 0.166 | AMP-activated protein kinase stimulant | 0.166 0.019 DBMET01404 0.105 0.064 DBMET02145 0.14 0.034 DBMET02146 0.125 0.045 DBMET02147 | DBMET01404 | |
| 0.039 | 0.04 | 0.04 | DNA gyrase subunit A inhibitor | 0.04 0.037 DBMET02145 | DBMET02145 | |
| 0.041 | 0.043 | 0.06 | Parathyroid hormone antagonist | 0.06 0.012 DBMET01404 0.043 0.039 DBMET02145 0.053 0.017 DBMET02146 | DBMET01404 | |
| 0.135 | 0.137 | 0.146 | Cyclin-dependent kinase 3 inhibitor | 0.146 0.105 DBMET01404 | DBMET01404 | |
| 0.047 | 0.049 | 0.053 | Protein kinase C eta inhibitor | 0.053 0.04 DBMET02145 | DBMET02145 | |
| 0.019 | 0.022 | 0.025 | Retinoid X gamma receptor agonist | 0.022 0.017 DBMET01404 0.023 0.017 DBMET02145 0.024 0.015 DBMET02146 0.025 0.014 DBMET02147 | DBMET02147 | |
| 0.024 | 0.03 | 0.028 | Complement C5a chemotactic receptor antagonist | 0.028 0.023 DBMET02147 | DBMET02147 | |
| 0.049 | 0.055 | 0.067 | Protein kinase C theta inhibitor | 0.067 0.026 DBMET02145 | DBMET02145 | |
| 0.019 | 0.026 | 0.022 | Retinoic acid gamma receptor agonist | 0.021 0.019 DBMET01404 0.022 0.016 DBMET02146 0.021 0.018 DBMET02147 | DBMET02146 | |
| 0.016 | 0.025 | 0.021 | Retinoic acid beta receptor agonist | 0.02 0.014 DBMET01404 0.021 0.011 DBMET02146 0.019 0.017 DBMET02147 | DBMET02146 | |
| 0.084 | 0.094 | 0.251 | Protein kinase (CK2) alpha inhibitor | 0.239 0.018 DBMET01404 0.251 0.016 DBMET02145 0.141 0.047 DBMET02146 0.136 0.051 DBMET02147 | DBMET02145 | |
| 0.015 | 0.028 | 0.019 | Retinoid X beta receptor agonist | 0.019 0.017 DBMET02147 | DBMET02147 | |
| 0.017 | 0.033 | 0.024 | Retinoic acid receptor agonist | 0.022 0.018 DBMET01404 0.024 0.014 DBMET02146 | DBMET02146 | |
| 0.052 | 0.07 | 0.073 | Cyclin B3 inhibitor | 0.073 0.043 DBMET02145 | DBMET02145 | |
| 0.042 | 0.062 | 0.057 | Myc inhibitor | 0.057 0.033 DBMET01404 0.05 0.044 DBMET02145 0.057 0.034 DBMET02146 | DBMET02146 | |
| 0.04 | 0.061 | 0.081 | CDK4/cyclin D1 inhibitor | 0.081 0.024 DBMET02145 | DBMET02145 | |
| 0.177 | 0.204 | 0.401 | Vasodilator, peripheral | 0.276 0.11 DBMET01404 0.401 0.055 DBMET02146 0.263 0.118 DBMET02147 | DBMET02146 | |
| 0.071 | 0.107 | 0.094 | DNA directed RNA polymerase inhibitor | 0.094 0.064 DBMET02145 | DBMET02145 | |
| 0.072 | 0.11 | 0.093 | ABCA1 expression enhancer | 0.087 0.072 DBMET01404 0.093 0.06 DBMET02146 0.092 0.062 DBMET02147 | DBMET02146 | |
| 0.127 | 0.17 | 0.172 | Death-associated protein kinase 2 inhibitor | 0.154 0.096 DBMET01404 0.172 0.065 DBMET02145 | DBMET02145 | |
| 0.03 | 0.095 | 0.06 | CDK4/cyclin D inhibitor | 0.06 0.039 DBMET02145 | DBMET02145 | |
| 0.04 | 0.12 | 0.067 | Protein kinase C alpha inhibitor | 0.067 0.048 DBMET02145 | DBMET02145 | |
| 0.036 | 0.14 | 0.072 | Heat shock protein 90 beta antagonist | 0.072 0.026 DBMET01404 0.064 0.034 DBMET02145 | DBMET01404 | |
| 0.029 | 0.137 | 0.058 | Cyclin D1 inhibitor | 0.058 0.046 DBMET02145 | DBMET02145 | |
| 0.056 | 0.164 | 0.078 | MAP kinase kinase 7 inhibitor | 0.076 0.058 DBMET01404 0.078 0.053 DBMET02145 | DBMET02145 | |
| 0.036 | 0.15 | 0.074 | Topoisomerase II alpha inhibitor | 0.074 0.057 DBMET01404 | DBMET01404 | |
| 0.022 | 0.136 | 0.053 | Protein kinase C epsilon inhibitor | 0.053 0.038 DBMET02145 | DBMET02145 | |
| 0.06 | 0.181 | 0.115 | Ribosomal protein S6 kinase inhibitor | 0.115 0.096 DBMET02145 | DBMET02145 | |
| 0.038 | 0.171 | 0.153 | Protein kinase (CK2) inhibitor | 0.147 0.034 DBMET01404 0.153 0.031 DBMET02145 | DBMET02145 | |
| 0.104 | 0.243 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 DBMET02146 | DBMET02146 | |
| 0.108 | 0.252 | 0.141 | Catenin beta inhibitor | 0.141 0.13 DBMET02146 | DBMET02146 | |
| 0.013 | 0.161 | 0.059 | Cyclin E inhibitor | 0.059 0.041 DBMET02145 | DBMET02145 | |
| 0.1 | 0.265 | 0.188 | Cardiotonic | 0.188 0.131 DBMET02147 | DBMET02147 | |
| 0.009 | 0.194 | 0.057 | CDK2/cyclin E inhibitor | 0.057 0.046 DBMET02145 | DBMET02145 | |
| 0.148 | 0.335 | 0.197 | MAP kinase kinase 3 inhibitor | 0.197 0.131 DBMET02145 | DBMET02145 | |
| 0.158 | 0.346 | 0.343 | Cyclophilin D inhibitor | 0.343 0.127 DBMET02146 0.33 0.138 DBMET02147 | DBMET02146 | |
| 0.056 | 0.246 | 0.158 | Protein-tyrosine phosphatase inhibitor | 0.158 0.071 DBMET02146 | DBMET02146 | |
| 0.008 | 0.22 | 0.049 | Sphingosine 1-phosphate receptor 1 agonist | 0.049 0.021 DBMET02147 | DBMET02147 | |
| 0.102 | 0.316 | 0.21 | 5 Hydroxytryptamine release stimulant | 0.21 0.113 DBMET02145 | DBMET02145 | |
| 0.071 | 0.293 | 0.124 | Sphingosine 1-phosphate receptor 2 agonist | 0.124 0.049 DBMET01404 | DBMET01404 | |
| 0.026 | 0.253 | 0.109 | Protein-tyrosine phosphatase 1B inhibitor | 0.109 0.07 DBMET02146 | DBMET02146 | |
| 0.047 | 0.279 | 0.081 | Vanilloid agonist | 0.081 0.068 DBMET02146 | DBMET02146 | |
| 0.022 | 0.255 | 0.078 | NMDA receptor antagonist | 0.074 0.073 DBMET01404 0.078 0.068 DBMET02146 | DBMET02146 | |
| 0.011 | 0.267 | 0.045 | Sphingosine 1-phosphate receptor agonist | 0.045 0.03 DBMET02147 | DBMET02147 | |
| 0.02 | 0.325 | 0.115 | Pim-1 kinase inhibitor | 0.115 0.046 DBMET02145 | DBMET02145 | |
| 0.017 | 0.371 | 0.084 | Pim-3 kinase inhibitor | 0.084 0.069 DBMET02145 | DBMET02145 | |
| 0.023 | 0.393 | 0.12 | GABA C receptor antagonist | 0.12 0.052 DBMET02145 | DBMET02145 | |
| 0.042 | 0.427 | 0.149 | Platelet adhesion inhibitor | 0.149 0.106 DBMET02146 0.145 0.112 DBMET02147 | DBMET02146 | |
| 0.059 | 0.478 | 0.167 | Hypoglycemic | 0.167 0.152 DBMET02146 | DBMET02146 | |
| 0.028 | 0.501 | 0.182 | Platelet antagonist | 0.182 0.115 DBMET02146 | DBMET02146 | |
| 0.043 | 0.697 | 0.291 | Sodium/bile acid cotransporter inhibitor | 0.291 0.088 DBMET02147 | DBMET02147 | |
| 0.011 | 0.686 | 0.091 | Chelator | 0.091 0.09 DBMET02147 | DBMET02147 | |
| 0.063 | 0.78 | 0.17 | Peptidyltransferase inhibitor | 0.17 0.146 DBMET02147 | DBMET02147 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |